CRISIL Limited (CRISIL) Fair Value & Analysis
Financial Services · IN · Market cap ₹299B
Fair value as of: Aug 2, 2026
From 13 valuation models · updated 11 days ago
Share price +10.7% over the past month.
A solid business, but screening 70% overvalued on our models.
What matters now
- The price sits above even our optimistic bull case (₹2,678). The favourable scenario is already priced in.
- The model range is unusually wide (₹1,021 to ₹2,678). The outcome hinges heavily on assumptions, so read the point estimate with caution.
- Solid but not exceptional quality (69/100) and above fair value, neither a clear bargain nor a standout compounder.
- For a financial, book-value and earnings-based methods matter more than a cash-flow DCF, which fits banks and insurers poorly.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 2, 2026.
How to read this chart
60‑month range ₹1,701 – ₹6,507 · fair‑value band ₹1,021 – ₹2,678 · the ₹4,507 price screens above the ₹1,362 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Aug 2, 2026.
Analysis
CRISIL Limited (CRISIL) currently trades at ₹4,507, while our model-based Fair Value estimate is ₹1,362, implying the stock looks roughly 69.8% overvalued today. The Quality Score stands at 69/100 (solid quality), in the Financial Services sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).
Over the trailing twelve months, CRISIL Limited generated revenue of ₹38.9B at a net margin of 21.6%. Revenue grew 30.1% year over year. It earns a return on equity of 27.4%. Net debt stands at ₹2.2B. Fundamentals as of Aug 2, 2026
Our scenario range runs from ₹1,021 (bear case) to ₹2,678 (bull case); at ₹4,507, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 26% below its 52-week high and 23% above its 52-week low, currently above its 200-day average. For context, the median of 10 Financial Services peers we cover trades at -53% fair-value upside, at -70%, CRISIL screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 13 models by family
Widest divergence: DCF Models (₹1,988) versus Asset-Based (₹277.92). Highest evidence: Growth DCF (80).
Notify me when CRISIL reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 2, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 66 · Market factors (momentum, volatility) 48
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
CRISIL Limited, an analytical company, provides ratings, research, and risk and policy consulting services in India, Europe, North America, and internationally. It operates through two segment, Rating Services; and Research, Analytics and Solutions.
Full company description
CRISIL Limited, an analytical company, provides ratings, research, and risk and policy consulting services in India, Europe, North America, and internationally. It operates through two segment, Rating Services; and Research, Analytics and Solutions. The company offers credit ratings for corporates, banks, and bank loans; credit analysis services; grading services; and analytical services. It also provides research and risk solutions, industry reports, customized research assignments, subscription to data services, training, and advisory services; and a range of risk management tools, analytics, and solutions for financial institutions, banks, and corporates. The company was formerly known as The Credit Rating Information Services of India Limited and changed its name to CRISIL Limited in December 2003. CRISIL Limited was incorporated in 1987 and is headquartered in Mumbai, India.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
CRISIL Limited reported revenue of ₹36.5B in FY2025 versus ₹23.0B in FY2021, a compound +12.2%/yr. Reported net income was ₹7.7B in FY2025, compounding +13.2%/yr from FY2021.
of which total revenue +10.2 pp · buybacks/dilution −0.2 pp
Absolute contributions in percentage points per year; they sum to the EPS growth rate. Start and end points are 3-year averages (details on hover).
CRISIL screens 70% overvalued. Compare with S&P Global Inc →
Peer Group
Financial Data & Stock Exchanges · 54 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Financial Data & Stock Exchanges median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Financial Data & Stock Exchanges stocks, each showing price versus our Fair Value estimate (as of Aug 2, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| S&P Global Inc SPGI | $450.84 | $196.36 | -56% |
| CME Group CME | $245.05 | $145.51 | -41% |
| Moody's Corporation MCO | $504.46 | $194.82 | -61% |
| Intercontinental Exchange, Inc ICE | $139.65 | $75.95 | -46% |
| Deutsche Börse AG DB1 | €260.90 | €142.42 | -45% |
| Nasdaq, Inc NDAQ | $88.08 | $41.12 | -53% |
| MSCI Inc MSCI | $604.71 | $214.91 | -64% |
| Coinbase Global, Inc COIN | $160.49 | $57.05 | -64% |
| Cboe Global Markets, Inc CBOE | $273.41 | $136.64 | -50% |
| Hithink RoyalFlush Information Network Co 300033 | ¥215.56 | ¥55.36 | -74% |
Compare CRISIL Limited with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Financial Services stocks →
Frequently asked questions
Is CRISIL Limited (CRISIL) overvalued or undervalued?
What is the fair value of CRISIL?
What is the quality score of CRISIL?
What is the revenue of CRISIL Limited (CRISIL)?
What is the net profit margin of CRISIL?
Does CRISIL Limited pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track CRISIL Limited and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.